|
2025
|
P/S
|
Medicated dermatological preparations and substances; Gels, creams and solutions for dermatologic... |
|
|
Invention
|
Minoxidil-containing suspension, preparation method therefor, and use thereof. Disclosed are a mi... |
|
|
Invention
|
Crystal form of selective parp-1 inhibitor hydrochloride, preparation method therefor and use the... |
|
2024
|
Invention
|
Compound composition of adapalene and dapsone, preparation method therefor, and use thereof. The ... |
|
|
Invention
|
Composition with synergistic therapeutic effect on acne lesions and preparation method therefor a... |
|
|
Invention
|
Crystal form of selective parp-1 inhibitor, preparation method therefor and use thereof. The pres... |
|
|
Invention
|
Crystal form of rp-6306, and preparation method therefor and use thereof. A crystal form of Lunre... |
|
2023
|
Invention
|
Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof. The pre... |
|
|
Invention
|
Crystal form of azd5305, preparation method therefor, and use therefor. The present application r... |
|
|
Invention
|
Crystal form of arv-110 and preparation method therefor and use thereof. The present application ... |
|
2022
|
Invention
|
Crystal forms of evobrutinib and salt thereof, and preparation method therefor and use thereof. D... |
|
|
Invention
|
Hydrate form of lazertinib mesylate, preparation method thereof and use thereof.
This applicatio... |
|
|
Invention
|
Hydrate crystal form of lazertinib methanesulfonate, preparation method therefor and use thereof.... |
|
|
Invention
|
Tolebrutinib salt and crystal form thereof, preparation method therefor, pharmaceutical compositi... |
|
|
Invention
|
Tolebrutinib crystal form, amorphous form, preparation method therefor and use thereof. Provided ... |
|
|
Invention
|
Resmetirom crystal form, preparation method therefor, and use thereof. Disclosed are a Resmetirom... |
|
|
Invention
|
Crystal form of brepocitinib tosylate, and preparation method and use therefor. Provided are a cr... |
|
|
Invention
|
Crystal form of tas-116, and preparation method therefor, pharmaceutical composition, and use the... |
|
2021
|
Invention
|
Crystal form of pyridazine derivative. Disclosed are a crystal form I of a compound as shown in f... |
|
|
Invention
|
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof.
The p... |
|
2020
|
Invention
|
Crystal form of tipifarnib and method of treatment thereof. The present invention relates to nove... |
|
|
Invention
|
Crystal form of acp-196 and method of treatment thereof. Crystalline forms of ACP-196, preparatio... |
|
|
P/S
|
Antibiotics; collyrium; food supplements consisting of trace elements; anti-infectives; pharmaceu... |
|
2019
|
Invention
|
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof. The pr... |
|
2018
|
Invention
|
Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefo... |
|
|
Invention
|
Pharmaceutical composition containing tacrolimus and preparation methods thereof. Disclosed are a... |
|
|
Invention
|
Crystal form of abemaciclib mesylate, preparation method therefor and pharmaceutical composition ... |
|
|
Invention
|
Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof. Provid... |
|
2017
|
Invention
|
Odm-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof. Th... |
|
|
Invention
|
Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor... |
|
|
Invention
|
Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4h-pyrrole[1,2-... |
|
|
Invention
|
Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4h-pyrrolo[1,2... |
|
|
Invention
|
Crystal form of acp-196 salt and preparation method, pharmaceutical composition, and use thereof.... |
|
2016
|
Invention
|
Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof. The pre... |
|
|
Invention
|
Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereo... |
|
|
Invention
|
Crystal form of acp-196, preparation method therefor and pharmaceutical composition thereof. Crys... |
|
|
Invention
|
Abt-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical co... |
|
|
Invention
|
Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod. The present i... |
|
|
Invention
|
Crystal form of dabrafenib mesylate and preparation method thereof. The present invention involve... |
|
|
Invention
|
Fenofibrate crystalline form and manufacturing method thereof. The present invention relates to F... |
|
|
Invention
|
Crystal form of dabrafenib and preparation method and use thereof. The invention relates to Cryst... |
|
2015
|
Invention
|
Inhibitor crystalline form and preparation method and use thereof. The present invention relates ... |
|
|
Invention
|
Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof. Th... |
|
|
Invention
|
Crystal form of dabrafenib and preparation method of use thereof. The invention relates to Crysta... |
|
2014
|
Invention
|
Solvate form m of trametinib dimethyl sulfoxide and methods of making and using thereof. The pres... |
